SCVD Faculty

Peter W Mason, PhD

Peter W Mason, PhDPeter Mason is the Head of Microbial Molecular Biology at Novartis Vaccines and Diagnostics (NV&D) in Cambridge, Massachusetts, where he oversees all research related to molecular biology aspects of NV&D's viral vaccine development. He has held this position since 2009, when he left his full-time position in the SCVD to join NV&D. Despite his relocation to Cambridge, Peter has continued to maintain his affiliation with UTMB though collaborations with members of the SCVD. Peter's work in virology began with postgraduate training in molecular virology at the University of Massachusetts in 1984. From 1986 to 1990, Dr. Mason was an Assistant Professor in the School of Medicine at Yale University, New Haven, Connecticut where he established a program in the molecular biology of flavivirus glycoprotein synthesis and virion assembly. As part of these studies, he played a critical role in design and pre-clinical evaluation of one of the first viral-vectored vaccines to be tested in man. In 1990, Peter began to work at the United States Department of Agriculture's Plum Island Animal Disease Center off the coast of Long Island, New York. In his position at the USDA, he shifted his primary research focus to study of foot-and-mouth disease virus (FMDV), an important agricultural pathogen that threatens livestock worldwide. During this time, he maintained a strong interest in flaviviruses, continuing to assist in development of viral-vectored vaccines, and he maintained his laboratory at Yale until 1995. Peter's work at Plum Island produced several new types of FMD vaccines, and when he left USDA in 2002 he was the head of the Center's FMD Research Unit. In 2002, Peter joined the faculty at UTMB as a Professor of Pathology and a Senior Scientist in the SCVD. Peter's contributions to infectious disease research at UTMB included his development of a new method to produce flavivirus vaccines (currently licensed to a major pharmaceutical company), and new methods to study flavivirus pathogenesis using unique single-cycle infectious particles.

Search PubMed for Dr. Mason's publications.